Now showing items 1-1 of 1

    • Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia 

      Kastelein J.J.P.; Van Leuven S.I.; Burgess L.; Evans G.W.; Kuivenhoven J.A.; Barter P.J.; Revkin J.H.; Grobbee D.E.; Riley W.A.; Shear C.L.; Duggan W.T.; Bots M.L. (2007)
      Background: Torcetrapib, an inhibitor of cholesteryl ester transfer protein, may reduce atherosclerotic vascular disease by increasing levels of high-density lipoprotein (HDL) cholesterol. Methods: A total of 850 patients ...